サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1798957

医療におけるマイクロチップの世界市場

Microchips in Medicine

出版日
ページ情報
英文 285 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.25円
医療におけるマイクロチップの世界市場
出版日: 2025年08月27日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 285 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

医療におけるマイクロチップの世界市場は2030年までに27億米ドルに達する

2024年に15億米ドルと推定される医療におけるマイクロチップの世界市場は、2024年から2030年にかけてCAGR 10.8%で成長し、2030年には27億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるドラッグデリバリーアプリケーションは、CAGR 12.2％を記録し、分析期間終了までに18億米ドルに達すると予測されます。ホームモニタリングアプリケーションセグメントの成長率は、分析期間中CAGR 8.1%と推定されます。

米国市場は4億130万米ドルと推定、中国はCAGR14.9％で成長予測

米国の医療におけるマイクロチップ市場は、2024年に4億130万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを14.9%として、2030年までに5億6,910万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ7.7%と9.6%と予測されています。欧州では、ドイツがCAGR約8.6%で成長すると予測されています。

世界の医療におけるマイクロチップ市場- 主要動向と促進要因のまとめ

マイクロチップは医療診断と治療法の未来をどう変えるか？

医療におけるマイクロチップ-植え込み型または摂取可能な医療用チップとしても知られる-は、医療専門家が幅広い健康状態を診断、モニター、治療する方法を再定義しています。多くの場合、米粒大かそれ以下の大きさのこれらの半導体ベースのデバイスは、バイタルサインのモニター、狙った場所への薬剤の送達、あるいは処方されたレジメンを患者が守っているかどうかの確認などに使用されています。錠剤に埋め込まれた摂取可能なセンサーチップは、摂取されるとデータを送信し、薬の摂取に関するリアルタイムのフィードバックを提供することができます。一方、埋め込み型チップは、長期的な生体信号追跡を通じて、心臓血管障害、てんかん、糖尿病などの慢性疾患をモニターします。

これらのチップは、生体適合性材料、微小電気機械システム（MEMS）、低電力半導体、無線データ伝送の融合です。通院やかさばる機器を必要とする従来のモニタリング技術とは異なり、マイクロチップは継続的、受動的、遠隔的な健康監視を提供します。世界のヘルスケアが個別化医療に軸足を移す中、これらのチップにより、医師はリアルタイムで収集される患者固有のデータに基づいて治療レジメンを調整することができます。

ヘルスケアにおけるマイクロチップの採用を促進する技術的ブレークスルーとは？

材料科学、ナノ加工、マイクロ流体工学における重要な技術革新が、医療現場におけるマイクロチップの展開を後押ししています。チップは現在、pH、グルコースレベル、電解質、酵素活性などの生化学シグナルを検出できるバイオセンサーを備えています。電力効率は大幅に改善され、チップは小型バッテリーやエネルギーハーベスティング機構（圧電システムや熱電システムなど）を使って数ヶ月から数年間機能することができます。超低消費電力集積回路（IC）や無線システム・オン・チップ（SoC）は、スマートフォンやクラウドプラットフォームへのシームレスなデータ伝送を可能にします。

最も有望な分野のひとつは、スマート・ドラッグデリバリー・システムであり、生物学的トリガーや遠隔操作に反応して薬剤を放出するようにチップがあらかじめプログラムされています。これは、がん治療やホルモン治療の前臨床試験で検証されています。ペースメーカーや神経刺激装置に埋め込まれたマイクロチップが、心臓のリズムや神経活動の連続データを中継します。最近の動向には、水分補給、体温、電気生理学的信号を非侵襲的に追跡できる、皮膚に埋め込まれたマイクロチップや電子タトゥーも含まれます。

さらに、ブロックチェーンに基づく安全なデータ伝送とAI主導の分析により、チップで生成されたデータが予測診断や集団健康管理で実用化されつつあります。FDAのような規制機関は、このようなチップの安全性と有用性を認めつつあり、それによって臨床採用が加速しています。

マイクロチップ技術の採用率が最も高い医療分野は？

慢性疾患管理は最も重要な応用分野の一つです。例えば糖尿病患者は、マイクロチップを搭載した持続グルコースモニター（CGM）の恩恵を受けており、インスリンポンプやヘルスケアプロバイダーへのノンストップデータ中継を可能にしています。心臓病学では、ペースメーカーや除細動器に内蔵された埋め込み型チップが、不整脈、心拍変動、心不全の初期兆候を追跡するために使用されています。神経学的アプリケーションには、発作、頭蓋内圧、脊髄活動をリアルタイムでモニターするチップが含まれます。

製薬分野では、摂取可能なマイクロチップを治験やコンプライアンス・モニタリングに組み込んでいます。Proteus Digital Healthはこの分野のパイオニアで、統合失調症やC型肝炎治療の服薬アドヒアランスを確認するために利用されている、摂取に成功したことを知らせる錠剤を発売しました。腫瘍学分野では、腫瘍内ドラッグデリバリーや熱焼灼ガイダンスのためのマイクロチップがテストされています。整形外科や人工関節の分野では、インプラントにチップを埋め込んで、治癒率、荷重動態、感染マーカーをモニターしています。

獣医学は、家畜やペットの追跡、診断、ワクチンモニタリングにRFIDマイクロチップが使用される、もう一つの並行成長分野です。地域別では北米が研究開発、臨床試験、商業化でリードし、患者データ規制と公衆衛生統合に強い関心を持つ欧州がこれに続きます。アジア太平洋-特に中国、日本、韓国-は、デジタルヘルスインフラストラクチャと半導体イノベーションにおける政府の取り組みにより急速に台頭しています。

世界の医療におけるマイクロチップ市場の成長を促進しているのは？

世界の医療におけるマイクロチップ市場の成長は、慢性疾患の負担増、患者中心の医療提供へのシフト、遠隔モニタリング技術の採用拡大など、いくつかの要因によってもたらされます。リアルタイムの継続的な診断に対する需要から、ヘルスケアシステムはマイクロチップを主流の治療経路に組み込むようになりました。センサーやチップの小型化と低価格化によって参入障壁が低くなり、入院・外来を問わず幅広い展開が可能になっています。

ヘルスケアにおけるスマートフォン、ウェアラブル、IoTプラットフォームの利用が並行して増加し、チップ対応診断のためのデジタルエコシステムが形成されつつあります。COVID-19の大流行は遠隔医療の受け入れを加速させ、非接触型モニタリングの必要性を浮き彫りにしました。製薬会社は、特に精神衛生と感染症分野で、薬剤コンプライアンスを改善するために経口製剤にチップを埋め込むことが増えています。

アウトカムベースの償還と予防医療を目指すヘルスケアセクターの動きは、マイクロチップが提供する継続的モニタリングツールをさらに後押ししています。米国、英国、欧州の一部では、デジタル治療薬や遠隔診断に対する償還コードが拡大しており、商業的な実行可能性を高めています。データプライバシーや生体適合性に対する懸念が、安全なアーキテクチャや不活性材料によって解決されるにつれて、マイクロチップを利用したヘルスケアの未来は、制度的、技術的、市場的に勢いを増し続けています。

セグメント

用途（ドラッグデリバリー用途、在宅モニタリング用途、その他用途）、最終用途（病院最終用途、調査最終用途、その他最終用途）

調査対象企業の例

  • Abbott Laboratories
  • Becton, Dickinson and Company（BD）
  • BioTelemetry（a Philips company）
  • Biotronik
  • Boston Scientific Corporation
  • Capsule Technologies（A Qualcomm Life Company）
  • Cepheid（a Danaher company）
  • Cochlear Limited
  • Dexcom Inc.
  • GE HealthCare
  • Hillrom（now part of Baxter）
  • Honeywell Life Sciences
  • Implantica
  • Masimo Corporation
  • Medtronic Plc
  • Microchip Biotechnologies Inc.
  • NXP Semiconductors
  • PerkinElmer（now part of Revvity）
  • Siemens Healthineers
  • Zimmer Biomet

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP39059

Global Microchips in Medicine Market to Reach US$2.7 Billion by 2030

The global market for Microchips in Medicine estimated at US$1.5 Billion in the year 2024, is expected to reach US$2.7 Billion by 2030, growing at a CAGR of 10.8% over the analysis period 2024-2030. Drug Delivery Application, one of the segments analyzed in the report, is expected to record a 12.2% CAGR and reach US$1.8 Billion by the end of the analysis period. Growth in the Home Monitoring Application segment is estimated at 8.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$401.3 Million While China is Forecast to Grow at 14.9% CAGR

The Microchips in Medicine market in the U.S. is estimated at US$401.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$569.1 Million by the year 2030 trailing a CAGR of 14.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.7% and 9.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.6% CAGR.

Global Microchips in Medicine Market - Key Trends & Drivers Summarized

How Are Microchips Transforming the Future of Medical Diagnostics and Therapeutics?

Microchips in medicine-also known as implantable or ingestible medical chips-are redefining how healthcare professionals diagnose, monitor, and treat a wide array of health conditions. These semiconductor-based devices, often the size of a grain of rice or smaller, are being used to monitor vital signs, deliver drugs at targeted locations, or verify patient adherence to prescribed regimens. Ingestible sensor chips embedded in pills can transmit data once ingested, providing real-time feedback on medication intake. Meanwhile, implantable chips monitor chronic diseases such as cardiovascular disorders, epilepsy, or diabetes through long-term biosignal tracking.

These chips represent a fusion of biocompatible materials, micro-electromechanical systems (MEMS), low-power semiconductors, and wireless data transmission. Unlike traditional monitoring techniques that require hospital visits or bulky equipment, microchips offer continuous, passive, and remote health surveillance. As global healthcare pivots toward personalized medicine, these chips enable physicians to adjust treatment regimens based on patient-specific data collected in real time-minimizing adverse drug reactions and maximizing therapeutic efficacy.

What Technological Breakthroughs Are Driving Adoption of Microchips in Healthcare?

Significant innovations in materials science, nanofabrication, and microfluidics are propelling the deployment of microchips in medical settings. Chips now feature biosensors capable of detecting biochemical signals such as pH, glucose levels, electrolytes, or enzyme activity. Power efficiency has been vastly improved, allowing chips to function for months or even years using miniature batteries or energy harvesting mechanisms (e.g., piezoelectric or thermoelectric systems). Ultra-low-power integrated circuits (ICs) and wireless systems-on-chip (SoCs) enable seamless data transmission to smartphones or cloud platforms.

One of the most promising areas is smart drug delivery systems, wherein chips are pre-programmed to release drugs in response to biological triggers or via remote control. This has been validated in preclinical studies for cancer treatment and hormone therapy. Another area of rapid growth is biosignal telemetry, where microchips embedded in pacemakers or neurostimulators relay continuous data on heart rhythms or neural activity. Recent developments also include skin-interfaced microchips and electronic tattoos capable of non-invasively tracking hydration, temperature, and electrophysiological signals.

Furthermore, blockchain-based secure data transmission and AI-driven analytics are making chip-generated data actionable in predictive diagnostics and population health management. Regulatory bodies such as the FDA are increasingly acknowledging the safety and utility of such chips, thereby accelerating clinical adoption.

Which Medical Fields Are Seeing the Highest Adoption Rates of Microchip Technologies?

Chronic disease management is among the most significant application areas. Diabetic patients, for instance, benefit from continuous glucose monitors (CGMs) equipped with microchips, enabling non-stop data relay to insulin pumps or healthcare providers. In cardiology, implantable chips inside pacemakers or defibrillators are used to track arrhythmias, heart rate variability, and early signs of heart failure. Neurological applications include chips that monitor seizures, intracranial pressure, or spinal cord activity in real time.

The pharmaceutical sector is integrating ingestible microchips into drug trials and compliance monitoring. Proteus Digital Health pioneered this segment, launching a pill that signals successful ingestion-a feature being utilized to verify adherence in schizophrenia and hepatitis C treatments. The oncology field is testing microchips for intra-tumoral drug delivery or thermal ablation guidance. In orthopedic and prosthetic applications, chips are being embedded in implants to monitor healing rates, load dynamics, and infection markers.

Veterinary medicine is another parallel growth segment where RFID microchips are used for tracking, diagnostics, and vaccine monitoring in livestock and pets. Geographically, North America leads in R&D, clinical trials, and commercialization, followed by Europe with a strong focus on patient data regulation and public health integration. Asia-Pacific-particularly China, Japan, and South Korea-is emerging rapidly due to government initiatives in digital health infrastructure and semiconductor innovation.

What Is Fueling Growth in the Global Microchips in Medicine Market?

The growth in the global microchips in medicine market is driven by several factors, including the rising burden of chronic diseases, a shift toward patient-centric healthcare delivery, and increased adoption of remote monitoring technologies. The demand for real-time, continuous diagnostics has prompted healthcare systems to integrate microchips into mainstream treatment pathways. Miniaturization and affordability of sensors and chips are reducing entry barriers, enabling broader deployment across both inpatient and outpatient settings.

A parallel rise in the use of smartphones, wearables, and IoT platforms in healthcare is creating a supportive digital ecosystem for chip-enabled diagnostics. The COVID-19 pandemic accelerated telehealth acceptance and highlighted the need for contactless monitoring-reinforcing the value of ingestible or implantable microchips. Pharmaceutical companies are increasingly embedding chips in oral formulations to improve drug compliance, especially in mental health and infectious disease segments.

The healthcare sector’s movement toward outcome-based reimbursement and preventative care further incentivizes continuous monitoring tools that microchips offer. Reimbursement codes for digital therapeutics and remote diagnostics are expanding across the US, UK, and parts of Europe, bolstering commercial viability. As concerns over data privacy and biocompatibility are addressed through secure architectures and inert materials, the microchip-enabled healthcare future continues to gain institutional, technological, and market momentum.

SCOPE OF STUDY:

The report analyzes the Microchips in Medicine market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Drug Delivery Application, Home Monitoring Application, Other Applications); End-Use (Hospitals End-Use, Research Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

  • Abbott Laboratories
  • Becton, Dickinson and Company (BD)
  • BioTelemetry (a Philips company)
  • Biotronik
  • Boston Scientific Corporation
  • Capsule Technologies (A Qualcomm Life Company)
  • Cepheid (a Danaher company)
  • Cochlear Limited
  • Dexcom Inc.
  • GE HealthCare
  • Hillrom (now part of Baxter)
  • Honeywell Life Sciences
  • Implantica
  • Masimo Corporation
  • Medtronic Plc
  • Microchip Biotechnologies Inc.
  • NXP Semiconductors
  • PerkinElmer (now part of Revvity)
  • Siemens Healthineers
  • Zimmer Biomet

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Microchips in Medicine - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Development of Smart Pills and Ingestible Microchips Throws the Spotlight on Digital Medicine
    • Rising Need for Continuous Patient Monitoring Drives Adoption of Implantable Microchips
    • Advances in Biocompatible Semiconductor Materials Enhance Medical Integration of Microchips
    • Growth in Remote Patient Management Solutions Spurs Demand for Chip-Enabled Wearable Devices
    • Use of Microchips for Drug Release Timing Enhances Precision Therapy Protocols
    • Surge in Interest in Digital Biomarkers Expands Use of Embedded Chips for Vital Sign Capture
    • Integration of NFC and RFID Technologies Drives Development of Smart Packaging in Pharma
    • Expansion of Electronic Health Monitoring Systems Strengthens Business Case for Chip-Enabled Devices
    • Innovation in Energy Harvesting and Wireless Charging Enhances Microchip Usability in Medicine
    • Growing Investment in Neurotechnology Spurs Development of Brain-Implanted Monitoring Chips
    • Advances in Lab-on-Chip Diagnostics Drive Miniaturized Point-of-Care Testing Applications
    • Regulatory Approvals for Ingestible Sensors Expand Commercialization of Diagnostic Microchips
    • Collaborations with Pharma Firms Accelerate Development of Companion Diagnostics Using Chips
    • Increase in Clinical Trials Using Sensor-Based Monitoring Enhances Microchip Market Penetration
    • Focus on AI Integration Within Chipsets Supports Personalized and Predictive Healthcare
    • Growth in Geriatric Care Needs Propels Use of Monitoring Chips in Long-Term Care Settings
    • Use of Blockchain and Smart Contracts in Chip-Enabled Drug Traceability Strengthens Compliance
    • Expansion of Telehealth Infrastructure Globally Spurs Use of Chip-Based Mobile Health Devices
    • Development of Closed-Loop Drug Delivery Systems Integrates Microchips for Feedback Control
    • Public Acceptance of Biometric Implants Opens Pathways for Wider Use of Microchips in Medicine
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Microchips in Medicine Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Microchips in Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Microchips in Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Microchips in Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Drug Delivery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Drug Delivery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Drug Delivery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Home Monitoring Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Home Monitoring Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Home Monitoring Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Research Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Research Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Research Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • JAPAN
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CHINA
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: China 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: China 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • EUROPE
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Microchips in Medicine by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Microchips in Medicine by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Microchips in Medicine by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • FRANCE
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: France 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: France 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • GERMANY
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Microchips in Medicine by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Microchips in Medicine by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Microchips in Medicine by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • INDIA
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: India 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: India 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Microchips in Medicine by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Microchips in Medicine by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Microchips in Medicine by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Microchips in Medicine by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Microchips in Medicine by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Microchips in Medicine by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AFRICA
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION